Schneider J, Ruiz-Torres A
Dtsch Med Wochenschr. 1977 Jan 28;102(4):116-8. doi: 10.1055/s-0028-1104851.
A total of 1109 determinations of digoxin concentration in serum were performed in 317 patients with cardiac failure during oral maintenance therapy with digoxin, beta-acetyldigoxin and beta-methyldigoxin. It was shown that the optimal therapeutic serum concentration (1.21 to 1.70 ng/ml) can be obtained reliably if the dosage of digoxin and its derivatives is based on the body weight. The daily doses recommended for oral maintenance therapy are 4mug/kg for beta-methyldigoxin, 5 mug/kg for beta-acetyldigoxin, and 8 mug/kg for digoxin. For initiating cardiac therapy the double maintenance dose can be prescribed once. Digoxin derivatives should be preferred to digoxin when choosing the drug.
对317例心力衰竭患者在口服地高辛、β-乙酰地高辛和β-甲基地高辛进行维持治疗期间共进行了1109次血清地高辛浓度测定。结果表明,如果根据体重确定地高辛及其衍生物的剂量,可可靠地获得最佳治疗血清浓度(1.21至1.70纳克/毫升)。口服维持治疗推荐的每日剂量为:β-甲基地高辛4微克/千克,β-乙酰地高辛5微克/千克,地高辛8微克/千克。开始心脏治疗时可一次给予双倍维持剂量。选择药物时应优先选用地高辛衍生物而非地高辛。